These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6199211)
1. Influenza A hemagglutinin-specific T cell clones strictly restricted by HLA-DR1 or HLA-DR7 molecules. Sterkers G; Henin Y; Lepage V; Fradelizzi D; Hannoun C; Levy JP Eur J Immunol; 1984 Feb; 14(2):125-32. PubMed ID: 6199211 [TBL] [Abstract][Full Text] [Related]
2. [Blockade of the anti-influenza specific proliferative response of cloned cell lines restricted either by HLA-DR7 or HLA-DR1 molecules or by a still-unknown molecule]. Sterkers G; Hannoun C; Lévy JP C R Seances Acad Sci III; 1983; 297(10):507-10. PubMed ID: 6198054 [TBL] [Abstract][Full Text] [Related]
3. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes. Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266 [TBL] [Abstract][Full Text] [Related]
4. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794 [TBL] [Abstract][Full Text] [Related]
5. HLA class II restriction governing cell cooperation between antigen-specific helper T lymphocytes, B lymphocytes and monocytes for in vitro antibody production to influenza virus. Fischer A; Sterkers G; Charron D; Durandy A Eur J Immunol; 1985 Jun; 15(6):620-6. PubMed ID: 3159585 [TBL] [Abstract][Full Text] [Related]
6. In vitro influenza virus-specific antibody production in man: antigen-specific and HLA-restricted induction of helper activity mediated by cloned human T lymphocytes. Lamb JR; Woody JN; Hartzman RJ; Eckels DD J Immunol; 1982 Oct; 129(4):1465-70. PubMed ID: 6180010 [TBL] [Abstract][Full Text] [Related]
7. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules. Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479 [TBL] [Abstract][Full Text] [Related]
8. Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones. Lamb JR; Eckels DD; Lake P; Johnson AH; Hartzman RJ; Woody JN J Immunol; 1982 Jan; 128(1):233-8. PubMed ID: 6172480 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of T cell proliferation by antibodies to synthetic peptides. Lamb JR; Zanders ED; Lake P; Webster RG; Eckels DD; Woody JN; Green N; Lerner RA; Feldmann M Eur J Immunol; 1984 Feb; 14(2):153-7. PubMed ID: 6607839 [TBL] [Abstract][Full Text] [Related]
10. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype. Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870 [TBL] [Abstract][Full Text] [Related]
11. Induction and activity of class II-restricted, Lyt-2+ cytolytic T lymphocytes specific for the influenza H5 hemagglutinin. Hioe CE; Hinshaw VS J Immunol; 1989 Apr; 142(7):2482-8. PubMed ID: 2466897 [TBL] [Abstract][Full Text] [Related]
12. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. Pinet V; Malnati MS; Long EO J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208 [TBL] [Abstract][Full Text] [Related]
13. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens. Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029 [TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility complex restriction of tetanus toxoid-specific human T lymphocyte clones. Schmitt C; Cogné M; Agrapart M; Ballet JJ Eur J Immunol; 1984 Dec; 14(12):1131-6. PubMed ID: 6083872 [TBL] [Abstract][Full Text] [Related]
15. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line. Yamamoto M; Yano A J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233 [TBL] [Abstract][Full Text] [Related]
16. Direct evaluation of antigen binding to human T lymphocyte clones: involvement of major histocompatibility complex products in antigen binding. Zanders ED; Feldmann M; Green N; Lamb JR Eur J Immunol; 1984 Dec; 14(12):1101-5. PubMed ID: 6335095 [TBL] [Abstract][Full Text] [Related]
17. Fine specificity of murine class II-restricted T cell clones for synthetic peptides of influenza virus hemagglutinin. Heterogeneity of antigen interaction with the T cell and the Ia molecule. Mills KH; Burt DS; Skehel JJ; Thomas DB J Immunol; 1988 Jun; 140(12):4083-90. PubMed ID: 2453566 [TBL] [Abstract][Full Text] [Related]
18. Antigen-specific and polyclonal immunoglobulin production induced by a cloned tetanus toxoid-specific T cell line. Friedman SM; Principato MA; Thompson GS; Teichman F J Immunol; 1983 Mar; 130(3):1164-70. PubMed ID: 6185573 [TBL] [Abstract][Full Text] [Related]
19. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation. Pawelec G; Schneider EM; Müller C; Wernet P Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396 [TBL] [Abstract][Full Text] [Related]
20. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. Yasukawa M; Zarling JM J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]